/
These statements represent our expectations or beliefs concerning, among other things, future revenue, earnings, growth strategies, new products and initiatives, dividend policies, future operations and operating results, expense saving initiatives, and future business and market opportunities. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a r…
$1.91
+$0.01 (+0.53%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-4.55% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 7.4% YoY. The question is whether this is cyclical or a structural shift.
ROIC dropped from -2.55% to -4.69%, capital efficiency is deteriorating. Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$38M
▼ -7.4% YoY
Net Income (TTM)
-$1M
▼ -254.2% YoY
Op. Margin
-5.06%
▼ -1.5pp YoY
ROIC
-5.87%
▼ -2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▼ -77.1% YoY
Op. Cash Flow (TTM)
-$7M
▼ -78.1% YoY
Net Debt
-$18M
Net Cash Position
Cash & Equiv.
$21M
5Y CAGR: -8.5%
Continue Research
Natural Health Trends (NHTC)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in .
On quality, Natural Health Trends scores 20/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 40.1%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Natural Health Trends scores 20 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -5.1% operating margin and a -5.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Natural Health Trends pays a regular dividend of about $0.77 per share per year (typically in quarterly installments), a yield of roughly 40.1% at the current price. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For NHTC's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. you should weigh NHTC's valuation and scores 20/100 on quality (lower-quality). It also yields about 40.1%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.